Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan, Republic of Korea.
Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Medicine (Baltimore). 2024 Mar 8;103(10):e37426. doi: 10.1097/MD.0000000000037426.
The aim of this study was to compare survival outcomes of 3 different radical hysterectomy (RH) types, namely total abdominal radical hysterectomy (TARH), total laparoscopic radical hysterectomy (TLRH), and laparoscopy-assisted radical vaginal hysterectomy (LARVH), in patients with FIGO stage IB2 cervical cancer. We retrospectively identified a cohort of patients who underwent RH for cervical cancer between 2010 and 2017. Patients with stage IB2 cervical cancer were included and were classified into TARH, TLRH, and LARVH treatment groups. Survival outcomes were estimated by the Kaplan-Meier method and compared with the log-rank test. Cox proportional hazards models were fit to estimate the independent association of RH technique with outcome. 194 patients were included in this study: 79 patients in the TARH group, 55 in the TLRH group, and 60 in the LARVH group. No significant differences were found in clinicopathological characteristics between the 3 RH groups. On comparing survival outcomes with TARH, both TLRH and LARVH showed no significant difference in terms of 5-year overall survival (TARH vs TLRH, P = .121 and TARH vs LARVH, P = .436). Conversely, compared to the TARH group, 5-year progression-free survival (PFS) was significantly worse in the TLRH group (P = .034) but not in the LARVH group (P = .288). Multivariate analysis showed that TLRH surgical approach (hazard ratio, 3.232; 95% confidence interval, 1.238-8.438; P = .017) was an independent prognostic factor for PFS in patients with IB2 cervical cancer. Our study suggests that in patients with FIGO stage IB2 cervical cancer, among the minimally invasive RH approaches, TLRH and LARVH, only TLRH approach was associated with worse PFS when compared with the TARH approach.
本研究旨在比较三种不同根治性子宫切除术(RH)类型的生存结果,即全腹式根治性子宫切除术(TARH)、全腹腔镜根治性子宫切除术(TLRH)和腹腔镜辅助根治性阴道子宫切除术(LARVH),在 FIGO 分期 IB2 宫颈癌患者中的应用。我们回顾性地确定了一组 2010 年至 2017 年间接受 RH 治疗宫颈癌的患者。纳入 IB2 期宫颈癌患者,并分为 TARH、TLRH 和 LARVH 治疗组。通过 Kaplan-Meier 法估计生存结果,并采用对数秩检验进行比较。Cox 比例风险模型用于估计 RH 技术与结局的独立相关性。本研究共纳入 194 例患者:TARH 组 79 例,TLRH 组 55 例,LARVH 组 60 例。三组 RH 患者的临床病理特征无显著差异。与 TARH 相比,TLRH 和 LARVH 在 5 年总生存率方面无显著差异(TARH 与 TLRH,P=0.121;TARH 与 LARVH,P=0.436)。相反,与 TARH 组相比,TLRH 组 5 年无进展生存率(PFS)显著较差(P=0.034),而 LARVH 组无显著差异(P=0.288)。多变量分析显示,TLRH 手术方式(风险比,3.232;95%置信区间,1.238-8.438;P=0.017)是影响 IB2 期宫颈癌患者 PFS 的独立预后因素。本研究表明,在 FIGO 分期 IB2 宫颈癌患者中,在微创 RH 方法中,TLRH 和 LARVH 仅 TLRH 方法与 TARH 方法相比,PFS 较差。